← European Medicine Shortage Tracker · all medicines

Levothyroxine sodium shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Levothyroxine sodium currently has availability issues reported in 3 European registers: Germany, Spain, Ireland.

Shortage  ATC H03AA01 · also listed as: Levothyroxin-Natrium · LEVOTIROXINA · Levothyroxine sodium · data refreshed 21 September 2026

Key facts

As of 21 September 2026, 3 of the 8 tracked registers list current availability issues for Levothyroxine sodium, covering 5 affected product presentations. The longest-running open report was filed in Spain on 2026-02-08 and has now been open for about 7 months. Where agencies state a cause, manufacturing problems lead with 4 of the 4 stated-cause reports. The furthest expected-resolution date currently on file is 2026-10-07; the earliest is 2026-09-29. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Spain reported first (2026-02-08), with Germany following roughly 6 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Spain, Ireland indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Levothyroxine sodium is coded H03AA01 — a medicine acting on systemic hormonal preparations — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇩🇪 GermanyShortage
L-Thyroxin Aventis 50 Mikrogramm Tabletten
+ 1 more products
L-Thyroxin Henning 75
2026-08-192026-10-07Unzureichende Produktionskapazitäten
Alternatives: N/A
register ↗
🇪🇸 SpainShortage
LEVOTIROXINA SANOFI 500 MICROGRAMOS POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 1 vial + 1 vial de disolvente
2026-02-082026-09-29Se puede solicitar como medicamento extranjero.
Alternatives: Se puede solicitar como medicamento extranjero.
register ↗
🇮🇪 IrelandShortage
Levothyroxine Teva 100 micrograms Tablets
+ 1 more products
Levothyroxine Teva 50 micrograms Tablets
2026-03-192026-08-07Manufacturing delay (Global)
Alternatives: Alternative(s) available — see the national register.
register ↗

New register reports per month

2026-02: 12026-03: 12026-04: 02026-05: 12026-06: 02026-07: 02026-08: 12026-09: 12026-022026-09

Full report history (5 register entries)

Every individual register entry for Levothyroxine sodium in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇩🇪 DEL-Thyroxin Aventis 50 Mikrogramm TablettenShortage2026-09-012026-09-30Unzureichende Produktionskapazitäten
🇩🇪 DEL-Thyroxin Henning 75Shortage2026-08-192026-10-07Unzureichende Produktionskapazitäten
🇮🇪 IELevothyroxine Teva 50 micrograms TabletsShortage2026-05-232026-07-24Manufacturing delay (Global)
🇮🇪 IELevothyroxine Teva 100 micrograms TabletsShortage2026-03-192026-08-07Manufacturing delay (Global)
🇪🇸 ESLEVOTIROXINA SANOFI 500 MICROGRAMOS POLVO Y DISOLVENTE PARA SOLUCION IShortage2026-02-082026-09-29Se puede solicitar como medicamento extranjero.

Frequently asked

Is Levothyroxine sodium currently in shortage in Europe?

Yes. As of 21 September 2026, availability issues are reported in: Germany, Spain, Ireland. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Levothyroxine sodium shortage expected to end?

Agency prognoses on file range from 2026-09-29 to 2026-10-07. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Levothyroxine sodium?

5 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Levothyroxine sodium availability data come from?

Directly from the official medicines-agency registers that list Levothyroxine sodium: BfArM (Germany), AEMPS CIMA (Spain), HPRA (Ireland). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Levothyroxine sodium — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/levothyroxine-sodium/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Levothyroxine sodium availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/levothyroxine-sodium/">Levothyroxine sodium shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Levothyroxine sodium: availability status across 3 European registers — European Medicine Shortage Tracker (MobiDoctor), 21 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.